219 related articles for article (PubMed ID: 12089788)
1. [WHO classification of Hodgkin's lymphoma and its molecular pathological relevance].
Hansmann ML; Willenbrock K
Pathologe; 2002 May; 23(3):207-18. PubMed ID: 12089788
[TBL] [Abstract][Full Text] [Related]
2. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
Peh SC; Kim LH; Poppema S
Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
[TBL] [Abstract][Full Text] [Related]
3. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
Hansmann ML; Küppers R
Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
[TBL] [Abstract][Full Text] [Related]
5. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease: classification and differential diagnosis.
Harris NL
Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
[TBL] [Abstract][Full Text] [Related]
7. [Hodgkin lymphoma. Classification and pathogenesis].
Foss HD; Marafioti T; Stein H
Pathologe; 2000 Mar; 21(2):113-23. PubMed ID: 10840817
[TBL] [Abstract][Full Text] [Related]
8. [Hodgkin's disease--an entity?].
Hansmann ML
Verh Dtsch Ges Pathol; 1992; 76():24-36. PubMed ID: 1283267
[TBL] [Abstract][Full Text] [Related]
9. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Hodgkin's disease: an update on histopathological and immunophenotypical features.
Fraga M; Forteza J
Histol Histopathol; 2007 Aug; 22(8):923-35. PubMed ID: 17503349
[TBL] [Abstract][Full Text] [Related]
11. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?
Harris NL
Ann Oncol; 1998; 9 Suppl 5():S45-56. PubMed ID: 9926237
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's lymphoma. An immunohistochemical profile in northern Iraq.
Fadhil MS; Al-Nueimy WM; Lazim AF
Saudi Med J; 2014 May; 35(5):448-53. PubMed ID: 24825804
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.
Bräuninger A; Schmitz R; Bechtel D; Renné C; Hansmann ML; Küppers R
Int J Cancer; 2006 Apr; 118(8):1853-61. PubMed ID: 16385563
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
Nam-Cha SH; Montes-Moreno S; Salcedo MT; Sanjuan J; Garcia JF; Piris MA
Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
[TBL] [Abstract][Full Text] [Related]
15. The Differential Diagnosis of Lymphocyte-rich Classical Hodgkin's Lymphoma and Lymphocyte Predominant Hodgkin's Lymphoma Using the R.E.A.L. Criteria. An Immunohistochemical Study on 45 Cases.
Hekimgil M; Soydan S; Doğanavşargil Yakut B; Ertan Y
Turk J Haematol; 2000 Dec; 17(4):163-70. PubMed ID: 27263633
[TBL] [Abstract][Full Text] [Related]
16. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
17. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's lymphoma: molecular targets and novel treatment strategies.
Yazbeck V; Georgakis GV; Wedgwood A; Younes A
Future Oncol; 2006 Aug; 2(4):533-51. PubMed ID: 16922620
[TBL] [Abstract][Full Text] [Related]
20. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.
Chan WC
Semin Hematol; 1999 Jul; 36(3):242-52. PubMed ID: 10462324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]